Predictors of Behavioral Obesity Treatment Outcomes
Rush University Medical Center · NCT05326477
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 230
- US sites recruiting
- 1
- Study start
- May 26, 2023
- Record last updated
- March 11, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Socioceconomically disadvantaged individuals typically have poor outcomes in behavioral weight loss interventions, but the reasons for this are unknown. This project will characterize the mechanisms through which adverse daily experiences and present bias -- a cognitive adaptation to harsh and unpredictable environments -- account for disparities in weight loss outcomes.
Being studied: Behavioral weight loss treatment
Conditions: Obesity
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age ≥18 years old
- Obesity (body mass index ≥30 kg/m2)
- Meets criteria for either the lower SES or higher SES cohort
Exclusion Criteria
- Not fluent in English
- Change in income or financial assets exceeding ±75% of federal poverty guideline within the past 12 months, or expected in the next 6 months, if this change would result in reclassification on SES.
- Previous or planned bariatric surgery, or concurrent engagement in other behavioral or pharmacological treatment for obesity
- Resides more than 20 miles away from Rush, or planning to move outside of this geographic area during the study period
- Body mass index ≥60 kg/m2, due to increased injury risk with exercise
- History of bariatric surgery, or current engagement in another weight loss therapy
- Lack of reliable access to cell or landline phone
- Medical contraindications to treatment, including osteoporosis, cognitive impairment (Montreal Cognitive Assessment ≤25), active substance abuse based on the World Health Organization's ASSIST screener, lack of physician clearance for participation, or serious medical illness (e.g., stage 3 or 4 heart failure, cancer, renal failure, etc.)
Recruiting US locations
Rush University Medical Center
Chicago, IL 60612
Site contact: Michele Li, MS, RD · 312-942-8260
Study contacts (from the official record)
- Bradley M Appelhans, PHD · 312-942-3477 · brad_appelhans@rush.edu
Similar studies in Illinois
All weight loss studies in Illinois →- RecruitingPhase 3
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Amgen
- Location
- Skokie, IL + 51 other US sites
- Eligibility basics
- Ages 18–99
- RecruitingPhase 2
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
AbbVie
- Location
- Chicago, IL + 58 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Alveus Therapeutics, Inc.
- Location
- Champaign, IL + 19 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Randomized Study on Transoral Outlet Reduction and Lifestyle Changes for Weight Regain After Gastric Bypass
Boston Scientific Corporation
- Location
- Chicago, IL + 8 other US sites
- Eligibility basics
- Ages 18+